Food nanoemulsion systems consisting of water and oleoresin capsicum (OC), polyoxythylene sorbitan esters (Tween 20, 40, 60, and 80), propylene glycol (PG), sucrose monostearate (SM), and their corresponding mixtures were formulated to use as food vehicles. Tween 80 produced OC nanoemulsions with stable dispersions as one-phase systems, and the dertermined emulsification efficiencies clearly distinguished the ability of the various surfactants to emulsify OC. The nanoemulsions were prepared by self-assembly, and the nanoemulsion areas were determined using phase diagrams by measuring the sizes of the emulsions. One-phase nanoemulsions were presented, with a multiple cloudy region and phase separation that were dependent on the particle size of the emulsion. The OC nanoemulsions prepared by ultrasonication using systems of OC/Tween 80/water, OC/Tween 80/water+PG, and OC/Tween 80/water+SM, resulted in particle sizes ranging from 15 to 100 nm. Finally, the nanoemulsions maintained their initial sizes during storage, ranging from 65 to 92 nm. The biopolymer nanoemulsion was prepared using self-assembly emulsification methods, and the capsaicin included oleoresin capsicum as the core material in the nanoemulsion. The particle sizes of the double-layer nanoemulsions prepared with alginate (AN) and chitosan (CN) were 20 nm or lower. The triple-layer nanoemulsion, which was prepared by complexation with chitosan and alginate (CAN), was successfully prepared with particle sizes on the nanoscale through the electrostatic interactions between the carboxylic groups and amine groups of the biopolymers. The Zeta potential value, which is an indicator of the overall stability and physicochemical properties of the nanoemulsion, of AN and CN were significantly higher than SN and CAN (p<0.01). In conclusion, the double-layer nanoemulsions incorporated with alginate and chitosan can be expected to improve the stability of nanoemulsion. In addition, this system holds promise for use in the production of functional foods containing functional ingredients.
Principal investigator: Dr. Chong-Tai Kim ctkim@kfri.re.kr